PNC Financial Services Group
ATNM icon

PNC Financial Services Group’s Actinium Pharmaceuticals ATNM Stock Holding History

PNC Financial Services Group’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-220
Closed -$354 – 4914
2025
Q1 		$354 Buy
+220
New +$279 ﹤0.01% 4699
2024
Q2 		– Sell
-100
Closed -$783 – 4762
2024
Q1 		$783 Buy
+100
New +$643 ﹤0.01% 4421
2023
Q2 		– Sell
-1,000
Closed -$9.45K – 4734
2023
Q1 		$9.45K Buy
+1,000
New +$10.6K ﹤0.01% 3834
2021
Q1 		– Sell
-6,616
Closed -$52K – 4104
2020
Q4 		$52K Hold
6,616
– – ﹤0.01% 2869
2020
Q3 		$64K Hold
6,616
– – ﹤0.01% 2579
2020
Q2 		$70K Hold
6,616
– – ﹤0.01% 2559
2020
Q1 		$38K Sell
6,616
-27,758
-81% -$197K ﹤0.01% 2782
2019
Q4 		$225K Hold
34,374
– – ﹤0.01% 1991
2019
Q3 		$237K Hold
34,374
– – ﹤0.01% 2039
2019
Q2 		$254K Hold
34,374
– – ﹤0.01% 2027
2019
Q1 		$494K Hold
34,374
– – ﹤0.01% 1642
2018
Q4 		$399K Buy
34,374
+6,616
+24% +$113K ﹤0.01% 1670
2018
Q3 		$617K Buy
+27,758
New +$565K ﹤0.01% 1564

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

PNC Financial Services Group's ATNM Position: Q2 2025 in Review

PNC Financial Services Group sold out of Actinium Pharmaceuticals (ATNM) in Q2 2025, closing a stake of 220 shares — an estimated $354 sold.

PNC Financial Services Group first reported a position in ATNM in Q3 2018 and held it in 13 quarters. The position peaked at $617K in Q3 2018. 63 funds tracked by Wall St. Rank hold ATNM as of Q2 2025.

  • PNC Financial Services Group reported no remaining Actinium Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 220 Actinium Pharmaceuticals shares in Q2 2025, an estimated $354.
  • PNC Financial Services Group first reported a position in Actinium Pharmaceuticals in Q3 2018 and held it in 13 quarters.
  • PNC Financial Services Group's Actinium Pharmaceuticals position peaked at $617K in Q3 2018.
  • 63 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2025.

Based on PNC Financial Services Group's 13F filing for Q2 2025, filed 8 Aug 2025.